Following the ouster of Carlos Tavares, Stellantis has been making big changes. As part of the shakeup, the company killed plug-in hybrids in North America and axed the fully electric Ram 1500 REV.

This tax season, many people could be hearing oversimplified versions of some complicated tax changes on 2025 tax returns.

A Ford recall tied to engine block heaters matters now because winter habits—plugging in overnight—can quietly create the ...

Felipe Nasr drove the No. 7 Porsche Penske Motorsport entry to the team's third consecutive win in the 2026 Rolex 24 at ...

The Czinger 21C is a $2.7 million hypercar with advanced tech and 3D-printed design. Its 1,250-horsepower hybrid powertrain and unique layout deliver extreme speed and futuristic driving experience.

Add Yahoo as a preferred source to see more of our stories on Google. Have you been dreaming of adding a museum-quality car to your collection? Well, you’re in luck—and lots of it. The museum, which ...

More than yet another insanely expensive toy, the Czinger 21C is the poster car for a new era of manufacturing as a service. More than yet another insanely expensive toy, the Czinger 21C is the ...

Have you been dreaming of adding a museum-quality car to your collection? Well, you’re in luck—and lots of it. The museum, which is located just outside of Paris in Étréchy, is the brainchild of ...

WASHINGTON/BRUSSELS, Aug 21 (Reuters) - The European Union will work to ensure lower U.S. tariffs on its car exports are applied retroactively to August 1, the bloc's trade chief said on Thursday, as ...

In July, President Donald Trump’s signature bill eliminated the penalties carmakers would have had to pay for not meeting fuel economy requirements. The car industry applauded the move, which, federal ...

An insurance comparison company used data to project premiums for the rest of the year. Some states could pay annual car insurance premiums over $3,400. Car insurance premiums are projected to ...

AbbVie is making a full strength play for the in vivo CAR-T market, snapping up Capstan Therapeutics for $2.1 billion to add an early-phase autoimmune drug candidate to its pipeline. Capstan is part ...